论文首页哲学论文经济论文法学论文教育论文文学论文历史论文理学论文工学论文医学论文管理论文艺术论文 |
【参考文献】
[1] Lasky JA, Ortiz LA. Antifibrotic therapy for the treatment of pulmonary fibrosis[J]. Am J Med Sci, 2001;322(4):213-221.
[2] 邹昌淇,杜庆成,周培宏. 联合用治疗大鼠早期矽肺的疗效观察[J].中华劳动卫生职业病杂志,2001;19(1):7-9.
Zou CQ, Du QC, Zhou PH. Study on therapeutic effect of combined use of antisilicosis drugs on early experimental of rats[J]. Chin J Ind Hyg Occup Dis, 2001;19(1):7-9.
[3] Selman M, Ruiz V, Cabrera, et al. TIMP1,2,3 and 4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment[J]. Am J Physiol Lung Cell Mol Physiol, 2000; 279(3): L562-L574.
[4] Suga M, Iycnaga K, Okamoto T, et al. Elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias[J]. Am J Respir Crit Care Med, 2000;162(5):1949-1956.
[5] Sheppard D. Pulmonary fibrosis: A cellular overreaction or a failure of communication?[J]. J Clin Invest, 2001;107(12):1501-1502.
[6] Ramos C, Montano M, GarciaAlvarez J, et al. Fibroblast from idiopathic pulmonary fibrosis and normal lungs differ in growth rate apoptosis and tissue inhibitor of metalloproteinases expression[J]. Am J Respir Cell Mol Biol, 2001;24(5):591-598.